SCHEMBL9685098

SCHEMBL9685098

CC(=O)c1ccc(CC(C)OS(=O)(=O)c2ccc(C)cc2)s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.38
HPGD P15428 2/20 0.37
ALDH1A1 P00352 7/20 0.36
RECQL P46063 2/20 0.36
LMNA P02545 1/20 0.36
PRNP P04156 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
KMT2A Q03164 4/20 0.35
TDP1 Q9NUW8 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
BLM P54132 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GSK3B P49841 1/20 0.33
AR P10275 1/20 0.33
MEN1 O00255 3/20 0.33
STAT3 P40763 1/20 0.33
PRSS1 P07477 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10726039 1.00 DHODH (0.38) DHODHHPGDALDH1A1RECQLLMNA
SCHEMBL10731053 0.88 HPGD (0.41) DHODHHPGDALDH1A1RECQLLMNA
SCHEMBL10731065 0.88 HPGD (0.41) DHODHHPGDALDH1A1RECQLLMNA
SCHEMBL9685326 0.86 DHODH (0.36) DHODHHPGDALDH1A1RECQLKMT2A
SCHEMBL10726091 0.86 DHODH (0.36) DHODHHPGDALDH1A1RECQLKMT2A
SCHEMBL10920536 0.78 HPGD (0.36) HPGDALDH1A1RECQLLMNAPRNP
SCHEMBL4056460 0.77 HPGD (0.44) DHODHHPGDALDH1A1RECQLLMNA
SCHEMBL9685089 0.75 DHODH (0.38) DHODHALDH1A1RECQLLMNAKMT2A
SCHEMBL9685246 0.74 HPGD (0.44) HPGDALDH1A1RECQLLMNAPRNP
SCHEMBL9685251 0.74 HPGD (0.44) HPGDALDH1A1RECQLLMNAPRNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5166218-A Antilipemic agents or antiglycemic agents HOFFMANN-LA ROCHE INC. (US) 1992-11-24 US disclosed
US-5064863-A Catabolic activity, obesity, diabetes HOFFMANN-LA ROCHE INC. (US) 1991-11-12 US disclosed
US-4871755-A Method for treating diabetes obesity and conditions characterized by increased protein breakdown with novel oxazolidines HOFFMANN-LA ROCHE INC. (US) 1989-10-03 US disclosed
US-4743604-A ANTIBESITY, ANTIDIABETIC, FEEDS HOFFMANN-LA ROCHE INC. (US) 1988-05-10 US disclosed
US-4652679-A Aziridine and phenethanolamine derivatives having antiobesity and anti-hyperglycaemic acitivity HOFFMANN-LA ROCHE INC. (US) 1987-03-24 US disclosed
US-4585796-A HYPOGLYCEMIC, ANTI-OBESITY HOFFMANN-LA ROCHE INC. (US) 1986-04-29 US disclosed